Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
C
|
Cameco Corp
NYSE:CCJ
|
CA |
|
Canadian Imperial Bank of Commerce
TSX:CM
|
CA |
|
Smartfit Escola de Ginastica e Danca SA
BOVESPA:SMFT3
|
BR |
|
G
|
Gatos Silver Inc
TSX:GATO
|
US |
|
Apple Hospitality REIT Inc
NYSE:APLE
|
US |
|
Fox Corp
NASDAQ:FOXA
|
US |
|
Monroe Capital Corp
NASDAQ:MRCC
|
US |
Wall St Price Targets
BMRN Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for BMRN is 91.69 USD with a low forecast of 55.55 USD and a high forecast of 126 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BMRN's stock price target?
Price Target
91.69
USD
According to Wall Street analysts, the average 1-year price target for BMRN is 91.69 USD with a low forecast of 55.55 USD and a high forecast of 126 USD.
What is the Revenue forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Net Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
27%
The compound annual growth rate for Net Income over the next 8 years is 27%.
